Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −5 vs. Q2 2022
- Shares held
- 3.87M
- −80.3K (−2.0%) vs. Q2 2022
- Total value
- $17.1M
- +$6.18M (+56.4%) vs. Q2 2022
- New holders
- 4
- 13 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 35 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 364 | $1.61K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 2,634 | $7.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,533 | $7.00K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $11.0K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 3,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 4,000 | $18.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,404 | $23.0K | 0.00% | −2,207−29.0% | Reduced |
| UBS Group AG | 7,500 | $33.0K | 0.00% | −295−3.8% | Reduced |
| Steward Partners Investment Advisory, LLC | 8,200 | $36.0K | 0.00% | +1,500+22.4% | Added |
| Aptus Capital Advisors, LLC | 10,360 | $46.0K | 0.00% | +150+1.5% | Added |
| Advisor Group Holdings, Inc. | 10,839 | $48.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,287 | $50.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,528 | $51.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 11,448 | $51.0K | 0.00% | −300−2.6% | Reduced |
| Marshall Wace, LLP | 13,024 | $58.0K | 0.00% | +13,024 | New |
| Cypress Capital Management LLC (WY) | 16,000 | $71.0K | 0.10% | +15,000+1,500.0% | Added |
| Boothbay Fund Management, LLC | 19,098 | $84.0K | 0.00% | −8,770−31.5% | Reduced |
| Janney Montgomery Scott LLC | 20,000 | $88.0K | 0.00% | +20,000 | New |
| Wells Fargo & Company | 20,383 | $90.0K | 0.00% | +2,486+13.9% | Added |
| Creative Planning | 30,681 | $136.0K | 0.00% | +30,681 | New |
| Citadel Advisors LLC | 31,007 | $137.0K | 0.00% | +5,322+20.7% | Added |
| IFP Advisors, Inc | 28,850 | $151.0K | 0.00% | +9,000+45.3% | Added |
| Morgan Stanley | 36,517 | $162.0K | 0.00% | −4,465−10.9% | Reduced |
| Liberty Wealth Management LLC | 40,000 | $176.0K | 0.05% | +10,000+33.3% | Added |
| Jmac Enterprises LLC | 40,430 | $179.0K | 0.05% | −5,000−11.0% | Reduced |
| Tru Independence Asset Management 2, LLC | 44,000 | $194.0K | 0.21% | +44,000 | New |
| Renaissance Technologies LLC | 55,700 | $246.0K | 0.00% | +38,600+225.7% | Added |
| Northern Trust Corp | 55,916 | $247.0K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 93,972 | $415.0K | 0.24% | −10,681−10.2% | Reduced |
| State Street Corp | 96,060 | $425.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 108,000 | $478.0K | 0.00% | +15,000+16.1% | Added |
| Millennium Management LLC | 143,359 | $634.0K | 0.00% | +33,363+30.3% | Added |
| Ikarian Capital, LLC | 189,935 | $839.0K | 0.42% | −63,497−25.1% | Reduced |
| Raymond James & Associates | 244,803 | $1.08M | 0.00% | +57,400+30.6% | Added |
| Geode Capital Management, LLC | 276,636 | $1.22M | 0.00% | +727+0.3% | Added |
| Abner Herrman & Brock LLC | 280,000 | $1.24M | 0.23% | +15,000+5.7% | Added |
| BlackRock Inc. | 468,320 | $2.07M | 0.00% | −5,413−1.1% | Reduced |
| Vanguard Group Inc | 1,427,902 | $6.31M | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −187,070−100.0% | Sold out |
| S.C. Financial Services, Inc. | 0 | $0 | 0.00% | −25,471−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −24,134−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,702−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −15,323−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,085−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,544−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| HighPoint Advisor Group LLC | – | – | – | – | Not filed |